Present address: Veterinary Specialty Group, Emergency & Referral Center, Sacramento, CA 95831, USA
Development of an ELISA to detect circulating anti-asparaginase antibodies in dogs with lymphoid neoplasia treated with Escherichia coli l-asparaginase*
Article first published online: 18 DEC 2012
© 2012 Blackwell Publishing Ltd
Veterinary and Comparative Oncology
How to Cite
Kidd, J. A., Ross, P., Buntzman, A. S. and Hess, P. R. (2012), Development of an ELISA to detect circulating anti-asparaginase antibodies in dogs with lymphoid neoplasia treated with Escherichia coli l-asparaginase*. Veterinary and Comparative Oncology. doi: 10.1111/vco.12014
*This research was presented, in part, at the Veterinary Cancer Society Annual Meeting, 2009.
- Article first published online: 18 DEC 2012
- National Institutes of Health. Grant Number: K08 DK082264
|vco12014-sup-0001-Figure s1.pptx||PowerPoint 2007 presentation||43K||Figure S1. Anti-asparaginase IgG responses are detectable at a plasma dilution of at least 1:1 600 000. Individual samples from treated (n = 3) and naïve (n = 3) dogs were serially diluted two-fold from 1:12 500 to 1:1 600 000; OD values from naïve dogs were used to calculate the assay sensitivity curve (dotted line). The data represent two independent repetitions of the experiment.|
|vco12014-sup-0002-Table s1.docx||Word 2007 document||40K||Table S1. Patient characteristics and l-asparaginase treatments of dogs in this study|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.